Skip to content
GHIAA Logo Small
Envelope Linkedin-in Twitter
  • Home
  • Our Work
    • Consulting
    • MAPGuide
    • Vaccine Manufacturing
  • About
    • About GHIAA
    • Team
  • News
    • GHIAA News
    • Newsletter
  • Contact
  • search
  • Home
  • Our Work
    • Consulting
    • MAPGuide
    • Vaccine Manufacturing
  • About
    • About GHIAA
    • Team
  • News
    • GHIAA News
    • Newsletter
  • Contact
  • search
 
search

The development of the MAPGuideⓇ platform and Equitable Access Toolkit was supported by the Wellcome Trust (grant numbers 219632/Z/19/Z, 221648/Z/20/Z and 225262/Z/22/Z).

If you are interested in providing funding or an in-kind contribution to support GHIAA’s continuing equitable access advocacy work and resource development activities, please contact us using the form below.  

Global Healthcare Innovation Alliance Accelerator is a 501(c)(3) non-profit recognized by the IRS.

Contact Us

Get In Touch

comms@ghiaa.org

Tel: 919-419-0300
919-906-4818
Fax: 919-419-8833

Attn: Executive Director
GHIAA
PO Box 14713
Research Triangle Park, NC 27709, USA

Browse

Home
MAPGuide
About GHIAA
Team
News

Contact Us

Get In Touch

comms@ghiaa.org

Tel: 919-419-0300
919-906-4818
Fax: 919-419-8833

Attn: Executive Director
GHIAA
PO Box 14713
Research Triangle Park, NC 27709, USA

Browse

Home
MAPGuide
About GHIAA
Team
News

Twitter Linkedin-in Envelope
comms@ghiaa.org

Privacy Policy

  • Privacy Policy
  • Privacy Policy

© 2025 Global Healthcare Innovation Alliance Accelerator. All Rights Reserved

Sign Up to Our Newsletter

Receive updates about GHIAA’s latest tools, resources and news.

I consent to receiving email updates from GHIAA and have read and agree to the Privacy Policy and Terms of Service..

Agreement Type

  • Any Agreement Types
  • Contract Manufacturing
  • License
  • Other
  • R&D Collaboration
  • R&D Funding
  • Supply/Purchase
  • Technology Transfer

Select Partner Type

  • Any Partner types
  • Academic institution
  • Funder
  • Government
  • Industry
  • Multilateral organization
  • Non-profit research organization
  • Product development partnership

Select Development Stage

  • Any Develoment stages
  • Discovery/Concept
  • Preclinical
  • Early clinical (through Phase 2)
  • Late clinical (Phase 3)
  • Commercialization
  • Field Testing

Select Technology

  • Any Technologies
  • Device
  • Diagnostic
  • Drug
  • Vaccine

Select Issue or Sub-issues

  • Equitable access
    • All Equitable access
    • Donation
    • Ensuring continuity
    • Access plans & principles
    • Preparedness & response
    • Affordable pricing
    • Territory access commitments
  • Business model
    • All Business model
    • Benefit sharing
    • Clinical trial conduct
    • Quality management
    • Regulatory strategy
    • Governance
    • Payment structures
    • Product supply
  • Protecting & sharing information
    • All Protecting & sharing information
    • Confidentiality
    • Information sharing
    • Publication of results
    • Technology transfer
  • Intellectual property
    • All Intellectual property
    • License grants
    • Ownership of IP
    • Protection of IP
  • Liability
    • All Liability
    • Indemnification & liability
    • Insurance
    • Representations & warranties
  • Term & termination
    • All Term & termination
    • Effects of termination
    • Term of agreement
    • Termination & withdrawal